Chameleon Biosciences Company
Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.
Technology:
Rare Genetic Disorders
Estimated Revenue:
$1M to $10M
Founded Date:
2017
Industry:
Gene Therapy
Headquarters:
San Anselmo, California, United States
Funding Status:
Seed